PHILADELPHIA, November 19, 2013 /PRNewswire/ --

Disaster relief workers and healthcare professionals in the Philippines can access Elsevier medical content through ClinicalKey and NLM Emergency Access Initiative

To support the people of the Philippines in the aftermath of typhoon Haiyan, Elsevier will provide free access to its primary online clinical information and reference tool, ClinicalKey, to all IPs originating from the country for 60 days.

In addition, Elsevier is participating in the National Library of Medicine's (NLM) Emergency Access Initiative (EAI) providing access to content from multiple publishers, including nearly 100 Elsevier journals, during the four-week free access period through December 8, 2013.

A collaborative partnership between the NLM and participating publishers, the EAI provides free access to full-text articles from over 650 biomedical serial titles and over 4,000 reference books and online databases to healthcare professionals and libraries affected by disasters. The EAI serves as a temporary collection replacement and/or supplement for libraries affected by disasters that need to continue to serve medical staff and affiliated users. It is also intended for medical personnel responding to the specified disaster. For further details visit: http://eai.nlm.nih.gov.

"Our thoughts and prayers go out to the people of the Philippines, especially to families who have been impacted by the disaster," said Gerrit Bos, Elsevier's Managing Director for the Health Sciences Division in Asia Pacific. "Situations like these require communities to band together to provide much-needed resources. As a provider of health, medical and patient care information, Elsevier is opening up the largest single reference site for clinical information, ClinicalKey, to frontline aid and medical workers to support their relief efforts during this challenging time."

ClinicalKey provides evidence-based clinical answers drawn from the single largest body of clinical content available including Medline, 500+ journals, 100+ books, drug information, guidelines, and patient education. Its clinically relevant search is powered by Elsevier's Smart Content, tagged with EMMeT (Elsevier Merged Medical Taxonomy), which enables ClinicalKey to understand clinical terms and thus discover medical content that is the most relevant, plus find related content that would be missed by other search engines.

Access to Elsevier's ClinicalKey is IP-validated throughout the country of the Philippines for hospitals, institutional libraries and other healthcare entities and professionals supporting the disaster relief efforts. Healthcare and disaster aid workers in the Philippines will be able to access ClinicalKey simply by going to http://www.clinicalkey.com.

Reed Elsevier businesses have contributed $45,000 to relief efforts, including a $10,000 donation to the International Red Cross from The Elsevier Foundation.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Jason Chan
Director, Corporate Relations, Asia Pacific
Elsevier
+65-6349-0240
j.chan@elsevier.com 

SOURCE Elsevier